Advertisement

Photodynamic Therapy for Retinal Hemangioblastoma: Treatment Outcomes of 17 Consecutive Patients

Published:April 19, 2021DOI:https://doi.org/10.1016/j.oret.2021.04.007

      Purpose

      To report the efficacy of photodynamic therapy (PDT) for management of retinal hemangioblastoma.

      Design

      Retrospective case series.

      Participants

      Seventeen patients with retinal hemangioblastoma treated with PDT.

      Methods

      The medical records of 17 patients with retinal hemangioblastoma treated with PDT were reviewed, and treatment outcomes were assessed. Photodynamic therapy was performed with 6 mg/m2 body surface area of verteporfin infused intravenously over 10 minutes activated by 50 J/cm2 laser light at 689 nm for 83 or 166 seconds.

      Main Outcome Measures

      Tumor control, subretinal and intraretinal fluid resolution, and visual outcome.

      Results

      Eighteen retinal hemangioblastomas in 17 eyes were treated with PDT. Median patient age was 31 years (mean, 36 years; range, 7–66 years), and median follow-up was 51 months (mean, 61 months; range, 2–144 months). Genetic testing confirmed von Hippel-Lindau disease in 8 of 17 patients (47%). The tumors were unilateral in all patients and unifocal in most patients (n = 13/17 [76%]). The tumor median basal diameter was 3.5 mm (mean, 3.4 mm; range, 1.5–6.0 mm) and median thickness was 2.1 mm (mean, 2.3 mm; range, 1.0–5.0 mm). The tumor location was juxtapapillary in 9 of 18 cases (50%). Associated findings included subretinal fluid (n = 14/17 [82%]) and macular edema (n = 12/17 [71%]). The median number of PDT sessions was 1.5 (mean, 1.8; range, 1.0–4.0). Standard duration of PDT (83 seconds) was used in all cases except 2, in which double duration (166 seconds) was used. Outcomes revealed tumor control in 13 of 18 tumors (72%), partial or complete resolution of subretinal fluid in 10 of 14 eyes (71%), and partial or complete resolution of macular edema in 7 of 12 eyes (58%), and stable or improved visual acuity in 12 of 17 eyes (71%). Photodynamic therapy-related transient exudative response was noted in 4 of 17 eyes (24%).

      Conclusions

      Photodynamic therapy is an effective treatment for both juxtapapillary and peripheral retinal hemangioblastomas, providing satisfactory rates of tumor control and visual stabilization and improvement. Patients should be monitored for PDT-related transient exudative response.

      Keywords

      Abbreviations and Acronyms:

      logMAR (logarithm of the minimum angle of resolution), PDT (photodynamic therapy), VEGF (vascular endothelial growth factor), VHL (von Hippel-Lindau)
      To read this article in full you will need to make a payment
      Subscribe to Ophthalmology Retina
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kreusel K.M.
        • Bechrakis N.E.
        • Krause L.
        • et al.
        Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study.
        Ophthalmology. 2006; 113: 1418-1424
        • Singh A.D.
        • Nouri M.
        • Shields C.L.
        • et al.
        Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease.
        Ophthalmology. 2001; 108: 1907-1911
        • Webster A.R.
        • Maher E.R.
        • Moore A.T.
        Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
        Arch Ophthalmol. 1999; 117: 371-378
        • Singh A.D.
        • Nouri M.
        • Shields C.L.
        • et al.
        Treatment of retinal capillary hemangioma.
        Ophthalmology. 2002; 109: 1799-1806
        • Kim H.
        • Yi J.H.
        • Kwon H.J.
        • et al.
        Therapeutic outcomes of retinal hemangioblastomas.
        Retina. 2014; 34: 2479-2486
        • Schmidt-Erfurth U.M.
        • Kusserow C.
        • Barbazetto I.A.
        • Laqua H.
        Benefits and complications of photodynamic therapy of papillary capillary hemangiomas.
        Ophthalmology. 2002; 109: 1256-1266
        • Aaberg Jr., T.M.
        • Aaberg Sr., T.M.
        • Martin D.F.
        • et al.
        Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy.
        Arch Ophthalmol. 2005; 123: 328-332
        • Stattin M.
        • Kralinger M.
        • Haas G.
        • et al.
        Photodynamic therapy for retinal capillary hemangioblastoma.
        Can J Ophthalmol. 2014; 49: e32-e35
        • Mashayekhi A.
        • Shields C.L.
        • Shields J.A.
        Transient increased exudation after photodynamic therapy of intraocular tumors.
        Middle East Afr J Ophthalmol. 2013; 20: 83-86
        • Cheung J.
        • Lee G.K.
        • Tham C.C.
        A large retinal capillary hemangioma in the anterior retina treated with photodynamic therapy.
        Case Rep Ophthalmol. 2012; 3: 1-4
        • Ziemssen F.
        • Voelker M.
        • Inhoffen W.
        • et al.
        Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy.
        Eye. 2007; 21: 1125-1126
        • Mennel S.
        • Meyer C.H.
        • Callizo J.
        Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.
        Acta Ophthalmol. 2010; 88: 610-613
        • Selver O.B.
        • Yaman A.
        • Saatci A.O.
        Temporary exudative retinal detachment following photodynamic therapy in a patient with retinal capillary hemangioblastoma.
        Middle East Afr J Ophthalmol. 2011; 18: 246-248
        • Wong Y.M.
        • Jalil A.
        • Mathews J.
        • Stanga P.E.
        Exudative retinal detachment following photodynamic therapy for retinal capillary hemangioma.
        Can J Ophthalmol. 2010; 45: 299-300
        • Goto S.
        • Oshima Y.
        • Tsujikawa M.
        • Nishida K.
        Massive exudative retinal detachment after photodynamic therapy for peripheral retinal capillary hemangioma.
        Retin Cases Brief Rep. 2013; 7: 86-88
        • Wittenberg L.
        • Ma P.
        Treatment of a von Hippel-Lindau retinal capillary hemangioma with photodynamic therapy.
        Can J Ophthalmol. 2008; 43: 605-606
        • Atebara N.H.
        Retinal capillary hemangioma treated with verteporfin photodynamic therapy.
        Am J Ophthalmol. 2002; 134: 788-790
        • Suh S.C.
        • Jin S.Y.
        • Bae S.H.
        • et al.
        Retinal capillary hemangioma treated with verteporfin photodynamic therapy and intravitreal triamcinolone acetonide.
        Korean J Ophthalmol. 2007; 21: 178-184
        • Baba T.
        • Kitahashi M.
        • Kubota-Taniai M.
        • et al.
        Subretinal hemorrhage after photodynamic therapy for juxtapapillary retinal capillary hemangioma.
        Case Rep Ophthalmol. 2011; 2: 134-139
        • Szabo A.
        • Gehl Z.
        • Seres A.
        Photodynamic (verteporfin) therapy for retinal capillary haemangioma, with monitoring of feeder and draining blood vessel diameters.
        Acta Ophthalmol Scand. 2005; 83: 512-513
        • Kim H.M.
        • Park K.H.
        • Woo S.J.
        Massive exudative retinal detachment following photodynamic therapy and intravitreal bevacizumab injection in retinal capillary hemangioma.
        Korean J Ophthalmol. 2015; 29: 143-145
        • Chen Y.
        • Liu H.
        • Zhang K.
        • Gao L.
        Massive exudative retinal detachment following photodynamic therapy for retinal hemangioma in von Hippel-Lindau syndrome.
        Photodiagnosis Photodyn Ther. 2014; 11: 250-253
        • von Buelow M.
        • Pape S.
        • Hoerauf H.
        Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma.
        Acta Ophthalmol Scand. 2007; 85: 114-116
        • Reynolds S.A.
        • Shechtman D.
        • Falco L.
        Complex juxtapapillary capillary hemangioma: a case report.
        Optometry. 2008; 79: 512-517
        • Tsai F.Y.
        • Lau L.I.
        • Chen S.J.
        • et al.
        Persistent exudative retinal detachment after photodynamic therapy and intravitreal bevacizumab injection for multiple retinal capillary hemangiomas in a patient with von Hippel-Lindau disease.
        J Chin Med Assoc. 2014; 77: 52-56
        • Rodriguez-Coleman H.
        • Spaide R.F.
        • Yannuzzi L.A.
        Treatment of angiomatous lesions of the retina with photodynamic therapy.
        Retina. 2002; 22: 228-232
        • Papastefanou V.P.
        • Pilli S.
        • Stinghe A.
        • et al.
        Photodynamic therapy for retinal capillary hemangioma.
        Eye. 2013; 27: 438-442
        • Hussain R.N.
        • Jmor F.
        • Damato B.
        • Heimann H.
        Verteporfin photodynamic therapy for the treatment of sporadic retinal capillary haemangioblastoma.
        Photodiagnosis Photodyn Ther. 2015; 12: 555-560
        • Yaman A.
        • Saatci A.O.
        • Arikan G.
        • Gunduz K.
        Involution of endophytic optic disc hemangioma with a single session of photodynamic treatment.
        Ann Ophthalmol (Skokie). 2007; 39: 63-66
        • Sachdeva R.
        • Dadgostar H.
        • Kaiser P.K.
        • et al.
        Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma.
        Acta Ophthalmol. 2010; 88: e334-e340
        • Zubicoa A.
        • Andonegui J.
        • Compains E.
        • et al.
        Combined treatment with intravitreal bevacizumab injection and photodynamic therapy for juxtapapillary retinal capillary haemangioma.
        J Fr Ophtalmol. 2020; 43: e139-e141
        • Alegret A.
        • Cebulla C.M.
        • Dubovy S.R.
        • et al.
        Photodynamic therapy and vitrectomy for a large optic nerve hemangioma with neovascularization and retinal detachment: a clinicopathologic correlation.
        Retin Cases Brief Rep. 2009; 3: 93-95
        • Tong B.
        • Xiao J.
        • Su G.
        The follow-up observation on the therapeutic effect of photodynamic therapy for the juxtapapillary retinal capillary hemangioma: a case report.
        BMC Ophthalmol. 2018; 18: 277
        • Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group
        Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report.
        Arch Ophthalmol. 1999; 117: 1329-1345
        • Milewski S.A.
        Spontaneous regression of a capillary hemangioma of the optic disc.
        Arch Ophthalmol. 2002; 120: 1100-1101
        • Molina M.C.
        • Paulo J.D.
        • Donado J.H.
        Spontaneous regression of a retinal capillary hemangioma.
        Retina. 2008; 28: 1554-1555
        • Huang C.
        • Tian Z.
        • Lai K.
        • et al.
        Long-term therapeutic outcomes of photodynamic therapy-based or photocoagulation-based treatments on retinal capillary hemangioma.
        Photomed Laser Surg. 2018; 36: 10-17
        • Liang X.
        • Shen D.
        • Huang Y.
        • et al.
        Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
        Ophthalmology. 2007; 114: 147-156
        • Wong W.T.
        • Liang K.J.
        • Hammel K.
        • et al.
        Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.
        Ophthalmology. 2008; 115: 1957-1964
        • Francis J.H.
        • Slakter J.S.
        • Abramson D.H.
        • et al.
        Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab.
        Am J Ophthalmol Case Rep. 2018; 11: 49-51